Eledon Pharmaceuticals
ELDN
ELDN
34 hedge funds and large institutions have $2M invested in Eledon Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$427K | |
| 2 | +$63.2K | |
| 3 | +$55K | |
| 4 |
Renaissance Technologies
New York
|
+$43.4K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$27K |
Top Sellers
| 1 | -$98K | |
| 2 | -$46K | |
| 3 | -$38.6K | |
| 4 |
NSEDCP
NJ State Employees Deferred Compensation Plan
Trenton,
New Jersey
|
-$34K |
| 5 |
Morgan Stanley
New York
|
-$31.2K |